You have 9 free searches left this month | for more free features.

NUV-868

Showing 1 - 9 of 9

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced Solid Tumor, Ovarian Cancer, Ovary Cancer Trial in United States (NUV-868, Olaparib, Enzalutamide)

Recruiting
  • Advanced Solid Tumor
  • +26 more
  • NUV-868
  • +2 more
  • Baltimore, Maryland
  • +3 more
Aug 1, 2022

Overweight, Obese, Type 1 Diabetes Trial in United States (CT-868, CT-868 Pen Injector, : CT-868 Pen Injector, Placebo)

Not yet recruiting
  • Overweight
  • +2 more
  • La Jolla, California
  • +15 more
Sep 29, 2023

Glioma, Glioma, Malignant, Glioma, Mixed Trial in United States (NUV-422)

Terminated
  • Glioma
  • +23 more
  • Tucson, Arizona
  • +11 more
Sep 30, 2022

Type 1 Diabetes Trial in Chula Vista (CT-868, Placebo, Victoza)

Recruiting
  • Type 1 Diabetes
  • Chula Vista, California
    Carmot Clinical Research Unit 101
Mar 30, 2023

Prostate Cancer, Prostatic Cancer, Cancer of Prostate Trial (NUV-422, Enzalutamide)

Not yet recruiting
  • Prostate Cancer
  • +7 more
  • (no location specified)
Jan 12, 2022

Obesity, Type2 Diabetes Trial in Mexico, United States (Placebo, CT-868)

Active, not recruiting
  • Obesity
  • Type2 Diabetes
  • Los Angeles, California
  • +5 more
Jul 24, 2022

Diabetes Trial in Chula Vista (CT-868 as SC Injection, Placebo as SC Injection, Active Comparator as SC Injection)

Completed
  • Diabetes
  • CT-868 as SC Injection
  • +2 more
  • Chula Vista, California
    Carmot Clinical Research Unit 101
Apr 30, 2022

Advanced/Metastatic Neuroendocrine Tumors Trial in Spain (Pazopanib)

Completed
  • Advanced/Metastatic Neuroendocrine Tumors
  • L'Hospitalet de Llobregat, Barcelona, Spain
  • +9 more
May 15, 2019